IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma

@inproceedings{Myers2015IGFBP2MT,
  title={IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma},
  author={Amy L. Myers and Lin Lin and Derek J. Nancarrow and Zhuwen Wang and Daysha Ferrer-Torres and Dafydd Gareth Thomas and Mark B. Orringer and Jules Lin and Rishindra M. Reddy and David G Beer and Andrew C Chang},
  booktitle={Oncotarget},
  year={2015}
}
Esophageal adenocarcinoma (EAC) patients commonly present with advanced stage disease and demonstrate resistance to therapy, with response rates below 40%. Understanding the molecular mechanisms of resistance is crucial for improvement of clinical outcomes. IGFBP2 is a member of the IGFBP family of proteins that has been reported to modulate both IGF and integrin signaling and is a mediator of cell growth, invasion and resistance in other tumor types. In this study, high IGFBP2 expression was… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 69 references

Regulation of protumorigenic pathways by insulin like growth factor binding protein2 and its association along with beta-catenin in breast cancer lymph node metastasis

  • P Sehgal, N Kumar, +5 authors P. Kondaiah
  • Molecular Cancer
  • 2013

Similar Papers

Loading similar papers…